PharmaLex Group further strengthens quality management and compliance services

Published: 12-Sep-2017
Regulatory Research & Development Finance

The merger with McGee Pharma International brings additional resource and significant experience in quality management and compliance services

As of 17 August, 2017, the PharmaLex Group, a leading specialist provider of development consulting, regulatory affairs, quality management and compliance, as well as pharmacovigilance, has completed the formal merger with McGee Pharma International (MPI).

MPI was founded in 2004 by Ann McGee and is based in Dublin, Ireland. They combine cutting edge EU and FDA quality and technical insight with best-in-class product manufacture (GMP), distribution (GDP) and post market (MAH) quality, compliance and technical support services.

These services are tailored to meet the needs of all of MPI’s 200+ clients.

This merger will help to strengthen our existing quality and compliance expertise provided by Complya, a division PharmaLex merged with earlier this year in the US.

The addition of one of the leading Irish consultancies will enable PharmaLex to provide both US and EU clients with industry leading quality management and compliance solutions.

This merger will help to accelerate and innovate compliant patient care. The focus on GMP, GDP and MAH compliance coupled with the strength of the Pharmalex Group in Regulatory Affairs, GCP and Pharmacovigilance, will enable the Group to integrate their approach across their operations to provide a seamless solution to client’s compliance requirements both in the US and EU.

The transaction also allows PharmaLex to better serve its clients in Ireland – a country with an important global economic pharma footprint.

"The merger allows us to build on our existing quality and compliance expertise and to further expand our geographic reach," explained Dr Thomas Dobmeyer, CEO PharmaLex.

“We are glad to have Ann, with her team of 50 technical experts on board, to service our client needs for EU and US GxP quality, compliance, manufacturing and product development,” Dr Tilo Netzer, CEO PharmaLex added.

“We are very excited to be joining the PharmaLex Group. Being part of an international service provider enables us to provide existing clients with a wider range of services as well as support clients in new markets and locations”, said Ann McGee, Managing Director, McGee Pharma International.

The PharmaLex Group now has more than 650 employees, with 25 offices in 14 countries and more than 600 satisfied clients worldwide.

  • Companies:
  • PharmaLex
  • McGee Pharma International
See more

You may also like

Regulatory

The right validation model: practical considerations and applications

Read more
It is widely accepted that validation in the life sciences industry follows a lifecycle model (1,2). What is not always clear is the specific model — or models — to follow and how to navigate through them in the real world. Hurdles to overcome include the specific deliverables that make up that model and how they change during the various interactions along the validation journey

Trending Articles

  1. You need to be a subscriber to read this article.
    Click here to find out more.
    Merck jumps on the GLP-1 therapeutic bandwagon by licensing Hansoh Pharma's HS-10535 Merck will be responsible for the development, manufacture and commercialisation of the investigational preclinical oral GLP-1 receptor agonist
  2. Newcells Biotech raises additional funding from investors Newcells Biotech, a leading drug discovery partner specialising in the development of in vitro models and bespoke assay services to improve the prediction of in vivo human outcomes, has raised a further £1.2m from existing investors Mercia Ventures, Northstar Ventures and North East Finance
  3. Thermo Fisher Scientific reveals MagMax Sequential DNA/RNA Kit to advance blood cancer research The kit combines DNA and RNA isolation chemistries into a single kit, simplifying sample extraction for a broad range of downstream molecular applications
  4. Accelerating and enhancing toxicology assessments Infographic guides users through ToxHQ’s speedy assessment features

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

You may also like

Regulatory

The right validation model: practical considerations and applications

It is widely accepted that validation in the life sciences industry follows a lifecycle model (1,2). What is not always clear is the specific model — or models — to follow and how to navigate through them in the real world. Hurdles to overcome include the specific deliverables that make up that model and how they change during the various interactions along the validation journey
Drug Delivery

PharmaLex reveals intention to merge with Cpharm

The merger plan is an important step to expanding PharmaLex’s footprint in Australia and New Zealand through Cpharm’s expert capabilities
Regulatory

European Commission adopts proposal to delay MDR deadlines

With thousands of outstanding conformity assessments for medical device certification under the Medical Device Regulation and limited capacity to manage these within the transition period, concerns about widespread product shortages in the EU market have been growing
Regulatory

Investment, outsourcing and globalisation: key trends for 2023

The start of 2023 has been challenging for the pharmaceutical industry. Economic constraints in Europe and the United States, staffing shortages, an increasingly complex regulatory environment and heightened competition for funding is putting pressure on companies
Finance

PharmaLex expands Nordic footprint across key business units with DRA Consulting merger

Alliance strengthens long-held collaboration and builds on overall regulatory, quality and market access services while advancing digital expertise
Regulatory

PharmaLex extends reach in Asia with Ascent merger

Headquartered in Tokyo, Ascent employs staff across Asia, and provides country-specific knowledge mixed with strategic advice from a global perspective
Manufacturing

PharmaLex and Phlexglobal announce merger

Through the merger, the company’s regulatory information management system will be used to support PharmaLex’s overall offering
Subscribe now